Global Potential Analysis of Human DNA Vaccines Market Size Worth USD 9,337 million by 2030 | CAGR of 9.5%
North America is expected to dominate the market & is projected to grow at the highest CAGR. Europe is the second-largest potential market
PORTLAND, OREGON, UNITED STATES, June 21, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, Potential Analysis of Human DNA Vaccines Market1 by Forecast Scenario: Global Opportunity Analysis and Industry Forecast, 2020-2030, the global potential analysis of human DNA vaccines market is expected to account for $3,762 million by 2020 and reach $9,337 million by 2030, growing at a CAGR of 9.5% from 2020 to 2030. Key opportunities for market expansion include the high need for vaccines for immunization & prevention of infectious diseases.
The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ ๐๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐๐ฎ๐ฆ๐๐ง ๐๐๐ ๐๐๐๐๐ข๐ง๐๐ฌ ๐๐๐ซ๐ค๐๐ญ?
Increase in vulnerability of the population to infectious diseases and rise in number of antibiotics-resistant pathogens have created the need for effective and low-cost vaccination, which would provide long-lasting immunity. DNA vaccines have potential advantages over traditional methods, for example, low risk of infection, easy transportation, and stability at room temperature. The potential of global human DNA vaccines market is expected to be rapid, owing to property of DNA vaccines of specific antigen targeting, reduced risk of infection compared to conventional vaccines, and improved stability. Moreover, relative ease of large-scale manufacturing compared to traditional approach and low storage requirement are anticipated to be present few key market opportunities.
๐๐๐ญ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) ๐๐ฅ๐ข๐๐ค ๐๐๐ซ๐ ๐ญ๐จ ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/request-sample/2309
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐จ๐ ๐๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐๐ฎ๐ฆ๐๐ง ๐๐๐ ๐๐๐๐๐ข๐ง๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
โข Inovio Pharmaceuticals, Inc.
โข GeneOne Life Science Inc.
โข MedImmune, Immunomic Therapeutics, Inc.
โข Astellas Pharma, Inc.
โข Pharos Biologicals
โข Sanofi S.A.
โข F. Hoffmann-La Roche AG
โข CureVac
โข Boehringer Ingelheim GmbH.
๐๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐๐ฎ๐ฆ๐๐ง ๐๐๐ ๐๐๐๐๐ข๐ง๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
By Product Type
โข Prophylactic DNA Vaccines: Intended to prevent diseases, such as those for infectious diseases like influenza, HPV, and COVID-19.
โข Therapeutic DNA Vaccines: Designed to treat existing conditions, including cancer and chronic infections.
2. By Technology
โข Electroporation: A method to enhance DNA vaccine delivery by using electrical pulses to increase cell permeability.
โข Gene Gun: A device that delivers DNA directly into cells using high-velocity microprojectiles.
โข Jet Injection: A method that uses a high-pressure stream to deliver DNA vaccines through the skin.
โข Liposome-based Delivery: Utilizes liposomes to encapsulate and deliver DNA into cells.
Nanoparticle-based Delivery: Employs nanoparticles to protect and deliver DNA to target cells.
3. By Application
โข Infectious Diseases: Vaccines targeting viruses (e.g., HIV, HPV, influenza) and bacteria (e.g., tuberculosis).
โข Cancer: Vaccines designed to treat various cancers, such as melanoma, prostate cancer, and breast cancer.
โข Allergies: Vaccines aimed at reducing or eliminating allergic reactions.
4. By End User
โข Hospitals: Facilities providing comprehensive healthcare services.
โข Clinics: Outpatient settings offering vaccinations and treatments.
โข Research Institutes: Organizations conducting clinical trials and research.
โข Pharmaceutical and Biotechnology Companies: Companies developing, manufacturing, and commercializing DNA vaccines.
5. By Region
โข North America: Includes the United States and Canada, with a focus on advanced healthcare infrastructure and high R&D investment.
โข Europe: Comprising Western and Eastern Europe, with significant contributions from countries like Germany, France, and the UK.
โข Asia-Pacific: Encompassing rapidly growing markets such as China, India, Japan, and Australia.
โข Latin America: Including Brazil, Mexico, and other countries with emerging healthcare sectors.
โข Middle East and Africa: Regions with varying degrees of market development and healthcare access.
6. By Distribution Channel
โข Direct Sales: Sales made directly from manufacturers to end-users, such as hospitals and clinics.
โข Distributors: Third-party entities that distribute vaccines to healthcare providers and facilities.
โข Online Sales: Platforms facilitating the purchase of vaccines, primarily for research and professional use.
7. By Age Group
โข Pediatrics: Vaccines developed for children and adolescents.
โข Adults: Vaccines targeting the adult population, typically aged 18-65.
โข Geriatrics: Vaccines designed for the elderly population, typically aged 65 and above.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/2309
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
1 https://www.alliedmarketresearch.com/potential-analysis-of-human-DNA-vaccines-market